Breath analysis is an evolving interdisciplinary science that involves physiology and medicine with analytical chemistry and engineering. It holds promise towards noninvasive clinical diagnosis as well as therapeutic and physiological monitoring[@b1][@b2][@b3][@b4][@b5][@b6][@b7][@b8][@b9][@b10]. In early years, researchers were mainly focused on the discovery of trace (\~ppbV to \~pptV ranges) gases in human breath as unique biomarkers for diseases. Despite the identification of more than 300 volatile organic compounds (VOCs) in exhaled breath during the last decade, not a single substance could be established as disease specific biomarker for clinical use. This was not only a consequence of inadequate fundamental knowledge on the origin, distribution and exhalation kinetics of individual markers but also due to insufficient understanding of complex physiological effects on breath VOC concentrations.

Pulmonary ventilation and perfusion are physiological determinants, which influence the alveolar gas exchange and thereby, VOC exhalation. Simple changes in physiology may have sudden and profound effects on breath VOC concentrations, which often override the actual pathophysiological effects. Recent studies have clearly demonstrated that hemodynamic changes induced by different breathing patterns or postures have immediate substance specific effects on VOC exhalation[@b11][@b12]. In addition, confounders such as environmental, dietary or oral/nasal cavity exposure and clinical contaminations are equally important as pathophysiological conditions or biological pathways[@b11][@b12][@b13].

Recent development and application of advanced real-time mass-spectrometric (MS) techniques such as selected ion flow-tube (SIFT)-MS, proton transfer reaction (PTR)-Quadrupol-MS and PTR-Time of flight (ToF)-MS along with online end-tidal/alveolar sampling have substantially reduced several confounding variables associated with sample storage, analysis time and mixed breath matrix[@b14][@b15][@b16][@b17][@b18]. Such improvements in sampling, analysis and statistical validation have led to the indication that concentration changes are more important than unique breath biomarkers[@b11][@b12][@b13]. At present, online monitoring of instant physiological changes in exhaled VOC profiles is possible with the required analytical sensitivity or resolution, which also enables clinicians to relate different biochemical and metabolic processes to exhaled VOCs[@b2][@b8][@b9][@b14][@b15][@b16][@b17][@b18].

We realized that the origin, physico-chemical characters and mostly alveolar gas exchange and compartmental distribution, are accountable for clinical interpretations of exhaled substances as breath biomarker[@b11][@b12]. Thus, the combined effect of the most influential physiological aspects such as hemodynamics and ventilation has to be investigated in extensive detail. We designed a study to investigate the effect of forced expiratory volume (FEV) manoeuvre onto the compositions of exhaled breath. Here, we applied real-time mass-spectrometry on healthy human subjects for breath resolved measurement of exhaled volatiles in parallel to continuous spirometry, side-stream capnometry and noninvasive monitoring of hemodynamic parameters. The following questions were addressed in detail:Is there any immediate physiological effect of FEV manoeuvre on VOC exhalation?Are those effects substance specific?Do such effects depend on ventilation and hemodynamic parameters?Can these changes be used to monitor lung functions or hemodynamic parameters?

Results
=======

Heat maps ([Fig. 1](#f1){ref-type="fig"}) represent an overview of relative changes for selected marker substances and respiratory parameters over the course of the entire experiment. These 18 VOCs were chosen because they had significantly higher concentration in expired air than in inspired air. Profound changes of exhaled VOC concentrations were induced within seconds, when respiratory and hemodynamic parameters changed during and after the FEV manoeuvre. Inspiratory concentrations remained constant during the experiment. Detailed data on relative changes (in %), normalized mean values and variations of different VOC concentrations, respiratory and hemodynamic parameters are listed in [Table 1](#t1){ref-type="table"} and [Supplementary Table 1](#S1){ref-type="supplementary-material"}.

Changes in exhaled VOC concentrations
-------------------------------------

All relative changes (in %) in VOC concentrations refer to the 4^th^ exhalation from the 1^st^ min ([Supplementary Fig. S1](#S1){ref-type="supplementary-material"}). Normalized mean alveolar concentrations (normalized onto 3^rd^ exhalation) of isoprene, furan and dimethyl-sulphide (C~2~H~6~S) increased by 21%, 12% and 7%, respectively during maximum exhalation (on 70^th^ s before the forced expiration) and decreased by 18%, 16% and 6% at forced expiration (on 77^th^ s). They decreased further by 37%, 32% and 13%, respectively, just after Forced~out~ (on 84^th^ s). Concentrations of these compounds then increased again by 21%, 13% and 5% and even exceeded baseline levels ([Fig. 2](#f2){ref-type="fig"} A) on 113^th^ s following the time profiles of stroke volume, cardiac output and pET-CO~2~ ([Table 1](#t1){ref-type="table"}). Less pronounced changes were observed for concentrations of acetonitrile, allyl-methyl-sulphide (C~4~H~8~S) and isopropanol (C~3~H~8~O). In this setup, acetone concentrations increased by 4.5% at Forced~out~ ([Fig. 2](#f2){ref-type="fig"}B). In contrast, concentrations of other compounds such as hydrogen sulphide (H~2~S), ammonia (NH~3~), formaldehyde (CH~2~O), methanol (CH~4~O), butane (C~4~H~8~), benzene (C~6~H~6~) and toluene (C~7~H~8~) etc. remained almost constant ([Fig. 1](#f1){ref-type="fig"}).

Changes in respiratory parameters
---------------------------------

All relative changes (in %) in respiratory parameters refer to the 4^th^ exhalation from the 1^st^ min ([Supplementary Fig. S1](#S1){ref-type="supplementary-material"}). Normalized mean values (normalized onto 3^rd^ exhalation) of expiratory tidal volume and minute ventilation increased by 106 and 41%, respectively during maximum exhalation (on 70^th^ s) and increased by 292 and 171% at forced expiration (on 77^th^ s). They came back to base line on 94^th^ second ([Fig. 2](#f2){ref-type="fig"}A). In contrast, pET-CO~2~ increased by 6% at maximum exhalation, decreased by 18% at forced expiration. After that it decreased further by 25% in the next breath. From the second breath after Forced~out~, pET-CO~2~ increased again, up to 10% below the base line and then remained constant at that level ([Fig. 2](#f2){ref-type="fig"}B). FIO~2~ remained constant throughout the experiment. V′O~2~ and V′CO~2~ were increased substantially by 29% and 88% at Forced~out~ ([Fig. 1](#f1){ref-type="fig"}).

Changes in hemodynamic parameters
---------------------------------

All relative changes (in %) in hemodynamic parameters refer to the 40^th^ s time point from the 1^st^ min ([Supplementary Fig. S1](#S1){ref-type="supplementary-material"}). Normalized mean values of stroke volume and cardiac output decreased by 14 and 6%, respectively during forced expiration, and increased by 4 and 14% in following 20 s. In contrast, pulse rate increased by 10% during FEV manoeuvre and decreased by 1% within the next 20 s ([Fig. 2](#f2){ref-type="fig"}A). All hemodynamic values returned to base level during the first 20 s of the third minute.

Detailed statistical comparisons of differences between breaths in relation to exhaled VOC concentrations and respiratory parameters and similar comparisons for hemodynamics parameters for consecutive measurement points are shown in [Table 1](#t1){ref-type="table"}.

Isoprene exhalation model for monitoring of FEV maneuvers
---------------------------------------------------------

The percentage of decrease in isoprene concentrations from Forced~out~ to following normal expiration are closely related to the percentage of FEV~1~ performances. The polynomial regression models ([Fig. 3](#f3){ref-type="fig"}) predicting percentage of performed FEV~1~ from the decrease in isoprene concentrations are as follows:***1***^***st***^***order polynomial regression equation****2nd order polynomial regression equation***

The overall results of different orders of regression are also presented in [Table 2](#t2){ref-type="table"}. As the third order of regression did not improve the R^2^ value significantly, it was excluded from the model.

Discussion
==========

In 50 volunteers we observed pronounced and immediate effects of forced respiratory maneuvers on exhaled VOC concentrations. FEV manoeuvre induced changes in both ventilation and hemodynamics, which subsequently changed VOC profiles. Correlations between concentrations of volatile substances e.g. isoprene, furan, and C~2~H~6~S and cardiac output, tidal volume, minute ventilation and pET-CO~2~ were observed. Comparatively less prominent effects were visible for C~4~H~8~S and acetonitrile. In contrast, compounds such as H~2~S, benzene, and toluene were almost unaffected by FEV manoeuvre induced physiological changes. FEV manoeuvre induced changes in VOC concentrations normalized to base line when respiratory and hemodynamic parameters went back to pre-FEV levels.

When subjects performed the FEV manoeuvre in a sitting position, they produced an extensive intrathoracic pressure, which significantly lowered venous return and ventricular preload. Eventually, according to the Frank-Starling Mechanism[@b19][@b20] stroke volume and cardiac output also decreased. Due to a baroreceptor mediated increase in pulse rate[@b21][@b22], cardiac output decreased moderately less than stroke volume during forced expiration. As tidal volume and minute ventilation increased during forced respiration exhaled VOCs could be expected to be diluted during these phases.

During FEV manoeuvre, all participants tried to exceed their maximal expiratory flow (MEF) rate and contracted their abdominal and intrathoracic muscles and diaphragm. As MEF depends on individual lung volume, intraluminal pressure falls rapidly from alveoli towards mouth during the effort of forced expiration. This dynamically collapsed the bronchioles, below the equal pressure point (i.e. P~intraluminal~ = P~transthoracic~) and MEF remained limited through intrathoracic airway resistance[@b23]. This may cause intrapulmonary shunt (lung areas, which are not ventilated but perfused)[@b24][@b25][@b26].

Statistically significant differences of substance concentrations occurring within the study period can be attributed to the FEV manoeuvre induced changes in hemodynamic and respiratory parameters. CO~2~ exhalation normally depends on cardiac output, minute ventilation and the extent of dead space ventilation. As spontaneously breathing volunteers may hyperventilate due to paced breathing, pET-CO~2~ tended to decrease gradually during the last 25 s before the manoeuvre. During the FEV manoeuvre, pET-CO~2~ only partially followed the time profile that would have been predicted from stroke volume and cardiac output. This is mostly due to factors such as expiratory time, mean alveolar partial pressure of CO~2~ (PCO~2~) and alveolar slope[@b27][@b28] becoming determinants for pET-CO~2~ under the conditions of forced respiration. At maximum exhalation (Max~out~) pET-CO~2~ increased significantly when stroke volume and cardiac output had already started to decrease. This increase is attributed to a change of alveolar slope during longer expiratory time, as alveolar blood-breath contact time for gas exchange was prolonged in order to empty additional lung volume (i.e. ERV). After Max~out~, pET-CO~2~ started to decrease pronouncedly during the maximum inhalation (Max~in~) and did not increase at forced expiration (Forced~out~) because of dilution during Max~in~ and due to the significant decrease in cardiac output[@b29]. After Forced~out~, once the participants did forced inspiration (Forced~in~) a further dilution of CO~2~ took place, which was reflected during the next normal exhalation. Although cardiac output already started to rise instantly after Forced~out~, due to the elevated pulse rate and stroke volume, pET-CO~2~ only increased from the second breath after the manoeuvre onwards. This was due to the relative hyperventilation going on until tidal volume and minute ventilation came back to baseline at the second breath after the manoeuvre. I.e. in this phase effects of cardiac output onto pCO~2~ were partially overridden by relative hyperventilation and consecutive dead space ventilation[@b30][@b31].

Acetone originates from lipolysis and glycolysis[@b32]. In our previous study, normalized mean alveolar concentrations of acetone remained almost constant during changes in postures. No effect of hemodynamic changes was observed on acetone, mainly due to its miscibility in water, high volatility, relatively large amount of production and higher rate of distribution within lung compartments[@b12]. From theory, especially from multiple inert gas elimination technique (MIGET)[@b33][@b34] one would expect that acetone being a highly soluble compound should behave similarly to CO~2~. However, in contrast to pCO~2~, there was a small (\~4.5%) but significant (P \< 0.001) increase in alveolar acetone concentrations at forced expiration. A possible explanation could be, that under the special conditions of forced expiration exchange phenomena from bronchial epithelium contributed to the exhaled concentrations of acetone[@b35][@b36]. Recent studies have also suggested partial exchange of VOCs with good water solubility and relatively higher blood:air partition coefficient within the bronchial tree in certain conditions such as increased bronchial perfusion or elevated exhalation flow[@b36][@b37][@b38]. Thus the unusual behaviour of acetone at Forced~out~ could be related to its extra-alveolar exchange within the airways. It might additionally be facilitated primarily by a pre-alveolar absorption during Max~in~ and afterwards by a post-alveolar revaporization during Forced~out~ due to the rapidly decelerating flow of forced expiration[@b17].

Isoprene originates mainly from cholesterol biosynthesis[@b39]. Isoprene exhalation normally is positively correlated with cardiac output and negatively correlated with ventilation[@b12]. The increase in isoprene concentrations from first 30 s onwards is in accordance with the consecutive small increase in cardiac output and the simultaneous decrease in minute ventilation. From Max~out~ till next normal exhalation isoprene exactly followed the time profile of pET-CO~2~. Similar to CO~2~, isoprene exhalation during the FEV manoeuvre must have been influenced by factors other than cardiac output and ventilation. Due to its very low aqueous solubility (0.009 mol/L at 20 °C)[@b12], alveolar concentrations of isoprene probably mirrored the pulmonary ventilation-perfusion effect during and after the manoeuvre. From the second normal exhalation after FEV manoeuvre, isoprene represented a perfusion driven increase during the following 15 s and then gradually decreased mirroring the cardiac output profile.

Other blood-borne compounds such as furan and C~2~H~6~S, which are related to smoking habits and bacterial emissions, respectively, also followed the exhalation pattern of isoprene due to their comparable solubility. Comparatively less pronounced changes were observed for compounds like acetonitrile and C~4~H~8~S, which originate from smoking/environment and dietary intakes, respectively[@b40]. Due to having a relatively higher aqueous solubility these two compounds did not exactly follow the behaviour of isoprene. On the other hand, H~2~S being produced mainly from oral cavity bacteria[@b11][@b12], remained almost unaffected. There was a minor decrease in exhaled H~2~S concentrations during forced expiration, which could be attributed to its dilution due to higher tidal volume at that moment. Benzene and toluene are two blood borne and lipophilic compounds, which accumulate mainly from environmental exposure[@b40]. Due to their high rate of distribution in fatty compartments alveolar profiles of both compounds remained almost constant. Although participants were most probably not exposed to environmental compounds all in the same way, benzene, toluene, furan and acetonitrile were detectable in all 50 subjects. This is due to the variable but ubiquitous exposure to benzene and toluene and to active and passive smoking in the case of furan and acetonitrile.

Inter-individual variations are inevitable in every *in vivo* study. As our study involved only 50 volunteers, we did not try to relate any demographic parameters such as age, sex or BMI to such variations. To reduce these variations, we normalized all VOC concentrations and respiratory parameters onto their corresponding values in the third breath of the measurement cycle. Similarly, hemodynamic parameters were normalized onto values from first 40^th^ s. 10--15 breaths/min is regarded as normal breathing in healthy human adults. In order to reduce additional variations in ventilation, all participants were asked to maintain a respiratory rate of 12/min by following a metronome sound.

Execution of a correct FEV manoeuvre mainly depends on the understanding of physician's instructions by the subject. In addition, there are several manual biases involved with both performance and analysis of such respiratory maneuvers[@b41][@b42][@b43] As these pulmonary function tests are mandatory for the diagnosis of obstructive[@b44] and restrictive[@b45][@b46][@b47] lung conditions, it is extremely important to have a reliable and unbiased quality assurance of such test. As participants of this study did not suffer from COPD or asthma, deviations from normal FEV~1~ range and Tiffeneau Score could be attributed to low performance in doing the test. Therefore, in each participant, deviations of actual FEV~1~ and Tiffeneau score (FEV~1~/FVC ratio) from expected values (predicted from the age, gender and BMI based population studies) was rated as percentage of performance. A second order polynomial regression [equation (2)](#eq2){ref-type="disp-formula"} turned out to reliably predict the percentage of FEV~1~ performance from the decrease in isoprene concentrations. In a perspective, exhaled concentrations of low-solubility substances such as isoprene might be used for quality control of Tiffeneau testing. This could be especially beneficial for lung function tests in sports medicine and physical fitness tests in healthy subjects and athletes.

As exhaled substance concentrations markedly depend on physiological parameters, such as breathing patterns, flow and airway resistances, unforeseeable and highly variable effects onto results have to be expected when any forced and non-physiological breathing maneuvers are used during breath sampling. Results of this study demonstrate that knowledge from pulmonary and airway gas exchange theory has to be taken into account when breath sampling is to be done in a reliable way. Analysis of exhaled VOC concentrations can provide additional information on physiology of respiration and gas exchange. Our results underline the importance of control and standardization of breath sampling with respect to tidal volume, respiratory rate, flow and airway resistance. In a perspective, breath VOCs could be used for quality assurance of lung function tests.

Methods and Materials
=====================

All experiments were carried out in accordance with Declaration of Helsinki guidelines. All experimental protocols were approved (Approval number: A 2015-0008) by the Institutional Ethics Committee (University Medical Centre Rostock, Rostock, Germany) and signed informed consents from all subjects were obtained before conducting measurements.

Experimental setup
------------------

We combined three devices, for real-time measurements of several parameters in parallel ([Fig. 4](#f4){ref-type="fig"}A).*PTR-ToF-MS* for continuous monitoring (time resolution: 200 ms) of breath VOC concentrations.*Flow-volume spirometry and side-stream capnometry* for breath-resolved measurement of lung function (e.g. respiratory rate, tidal volume, minute ventilation) and pET-CO~2~.*Volume clamp method* for non-invasive determination of hemodynamics (e.g. blood pressure, cardiac output, pulse rate).

All devices were synchronised, and data acquisition was initiated simultaneously.

Measurement protocol for healthy volunteers
-------------------------------------------

Demographic data from 50 healthy participants (27 males, 23 females; aged between 21--54 years) are shown in [Table 3](#t3){ref-type="table"}. In order to explain and prepare the test procedures, volunteers were requested to appear at least 30 min before the actual measurements. Participants were asked to breathe normally (Respiratory rate = 12/minute) through a sterile mouthpiece following a metronome sound to determine normal tidal volume (VT). After 13 normal breaths, volunteers performed the forced expiratory volume (FEV) manoeuvre and then again breathed normally until the end of the third minute ([Fig. 4](#f4){ref-type="fig"}B).

The FEV manoeuvre consists of 4 distinct steps:a maximum exhalation (Max~out~): Exhalation of tidal volume (VT) and expiratory reserve volume (ERV)a maximum inhalation (Max~in~): Inhalation of the vital capacity (VC) corresponding to tidal volume (VT), expired (ERV) and inspired (IRV) reserve volumes,followed by a forced expiration (Forced~out~) to exhale the vital capacity (VC) as fast as possibleand finally a forced inspiration (Forced~out~) to inhale the vital capacity corresponding to tidal volume (VT), expiratory (ERV) and inspiratory (IRV) reserve volumes as fast as possible (spirogram in [Fig. 4](#f4){ref-type="fig"} B).

Nose clips were used to prevent any partial nasal exhalation during the measurements. According to ERS guidelines, we repeated the entire measurement cycle (3 min) in all volunteers to check any possible differences in the performance and execution of the FEV manoeuvre. As we did not find any significant differences between these measurements, the first test of each participant was used for statistical evaluation.

### PTR-ToF-MS for breath VOCs analysis

#### Instrumentation

We used an online PTR-ToF-MS-8000 (Ionicon Analytik GmbH, Innsbruck, Austria) for continuous real-time measurement of volatile organic compounds (VOCs) in breath. The working principle and conditions of the instrument for breath sampling were described in several studies[@b11][@b12]. Concisely, the soft ionisation of VOCs is based on a non-dissociative proton transfer reaction \[VOC + H~3~O^+^ → (VOC)H^+^ + H~2~O\], which ionises VOCs with relatively higher proton affinity than water. Protonated VOCs are then detected in a high resolution reflectron time-of-flight mass spectrometer (Tofwerk AG, Thun, Switzerland) according to their mass to charge (m/q) ratio. There is no requirement for preconcentration and ambient air can be used as buffer gas. We sampled breath in a continuous side-stream mode by using a 6 m long inert and heated silco-steel transfer-line (ID 0.75 mm, Restek, Bellafonte, USA), which was connected to the sterile mouthpiece. [Table 4](#t4){ref-type="table"} shows, PTR-ToF-MS-8000 measurement parameters.

A time resolution of 200 ms for data acquisition was realized by the associated ToF-DAQ Software. After every minute of measurement, a file was automatically recorded and the mass scale was calibrated by using the following masses: H~3~O^+^-isotope: 21.0226 Th; NO^+^: 29.9980 Th; protonated acetone: 59.049 Th.

#### Data processing

All VOCs were measured in counts per seconds (cps) and their intensities were normalised onto primary ion (H~3~O^+^) counts. We used a custom-made data processing algorithm called 'breath tracker' (MATLAB version 7.12.0.635, R2011a) to identify alveolar and inspiratory phases of breath[@b11][@b12]. Any endogenous and blood-borne compound that has relatively higher signal intensity in expiration can be used as a tracker mass. In our study, acetone was used as the tracker mass.

### Spirometry and capnometry for measurements of respiratory parameters

We conducted breath-resolved spirometry and side-stream capnometry by using the Oxycon Mobile device (CareFusion GmbH, Hoechberg, Germany). Subsequent data analysis was performed by the JLAB Software 5.3x (Version 02.00). This equipment complies with all criteria of both European Respiratory Society (ERS) and American Thoracic Society (ATS) standards and has been validated for clinical and laboratory practice[@b48][@b49].

The main device consists of a flow-volume sensor (TripleV unit), a gas sensor box (SBx/CPX unit), a data exchange unit (DEx transmitter) and a power calibration unit (PCa receiver). An ambient unit and a gas analyser are integrated in the SBx unit, which determine the ambient conditions and O~2~/CO~2~ content in calibration gas (Standard content: 5% CO~2~ and 16% O~2~), respectively. The TripleV unit comprises of a rotatory flow sensor, a main-stream volume sensor (electrical infrared) and a sample tube, connected to the side-stream capnometer (integrated in SBx unit). The TripleV-SBx unit allows continuous breath-by-breath and intra-breath measurements of spirometric (lung functions) and capnometric (pET-CO~2~) values in real-time. The DEx is used for recording, storage and telemetric transfer of data to the PCa unit. The PCa unit receives telemetric data as a PC-interface to the JLAB Software and is also used actively during calibrations. Prior to inclusion of every new participant, measurement of the ambient conditions as well as volume and gas calibrations were performed. General respiratory parameters such as respiratory rate, tidal volume, minute ventilation, FIO~2~ and pET-CO~2~ etc. were recorded breath-by breath. The FEV manoeuvre was performed during an intra-breath phase and additional lung functions such as FEV~1~ (forced expiratory volume in 1^st^ s), FVC (forced vital capacity) and EELV (end expiratory lung volume) etc. were recorded for subsequent time points. Additional metabolic parameters such as RER, V′O~2~, V′CO~2~ were assessed by this system. These values usually are determined during stable conditions of rest or exercise[@b50][@b51]. As these values are calculated from spirometric data, the sudden and exceptional manoeuvre our volunteers were told to do induced artificial variations which, therefore, do not mirror any real change of these metabolic parameters.

### Volume clamp method for non-invasive monitoring of hemodynamics

Any invasive approach for hemodynamic monitoring in healthy volunteers is not possible for ethically reasons. Thus, we used a ClearSight System EV1000 (Edwards Lifesciences, California, USA) for continuous, non-invasive measurement of hemodynamic parameters in real-time. The instrument and associated volume clamp method are described in previous study[@b12]. Briefly, a suitable finger-cuff is used for each participant to clamp the middle phalanges of either index or middle finger. A heart reference sensor calibrates the relative position of the finger-cuff with respect to the heart. The finger-cuff (with infrared sensing technology) and the pressure controller measure blood pressure variations over time, which results in a photo-plethysmogram. The initial blood pressure waveform and associated parameters are recorded approximately in first 20 s. Blood pressure, pulse rate, stroke volume and cardiac output are recorded and calculated in 20 s intervals from the arterial waveform, which is derived from the photo-plethysmogram and pressure waveform. Although the standard errors for absolute values in this system range between 20% in healthy subjects, relative changes in all parameters are tracked with acceptable accuracy[@b12][@b52].

Statistical analysis
--------------------

### Comparison of differences

Every fourth breath along with the maximum and forced exhalation (from the 2^nd^ min) was included for statistical comparisons for VOC concentrations and respiratory parameters. We excluded the hemodynamic data from the first 20 s of the measurement cycle to avoid any possible artefact from the arterial waveform calibration time of the ClearSight System. Thus every data point for hemodynamic parameters was compared to the 40^th^ s time point from the first minute.

Statistically significant differences between VOC concentrations, respiratory and hemodynamic parameters were determined by means of repeated measurement ANOVA on ranks (Friedman repeated measures analysis of variance on ranks, Shapiro-Wilk test for normal distribution and post hoc Student--Newman--Keuls method for pairwise multiple comparisons between all groups; P-value \< 0.05) using SigmaPlot (version 13). From all pairwise comparisons, we selected those referring to the 4^th^ breath and 40^th^ s of the 1^st^ min. For a minimum detectable difference in mean substance intensities of 400 cps and an estimated standard deviation of 400, 10 groups, each group size of 50 and alpha = 0.05 the power of the test was 0.959. A schematic overview of the statistical comparisons is presented in [Supplementary Fig. S1](#S1){ref-type="supplementary-material"}.

### Correlation analysis

In order to investigate correlations between the behaviour of VOC concentrations and the respiratory and hemodynamic parameters during and after the manoeuvre, we applied polynomial regression analysis (SigmaPlot; version 13).

### Modelling of VOC exhalations to monitor FEV performances

FEV is a standard respiratory manoeuvre, which is discussed in the measurement protocol. Each manoeuvre consists of two exhalations; a maximum exhalation (Max~out~) followed by a forced expiration (Forced~out~). In order to model some VOCs of interest during and after the manoeuvre those two exhalations and the very next normal exhalation were used for modelling. As the volume of Max~out~remained very reproducible in any individual, we reduced inter-individual variations in our analysis by normalizing the absolute VOC concentrations in both Forced~out~ and the following normal exhalation onto the Max~out~ point for each participant. Forced vital capacity (FVC) is the total volume of Forced~out~ after a Max~in~ and FEV~1~ is the volume exhaled within the 1^st^ s of forced expiration. FEV~1~/FVC ratio (Tiffeneau-Pinelli index) is an important parameter in lung function testing within the field of pulmonology and respiratory medicine. Performance of FEV~1~ and analysis of Tiffeneau score lies on considerable manual biases. In order to establish an unbiased quality control of such test, we investigated the dependency of VOC exhalations on the maneuvers. Thus, we compared the relative changes in substance concentrations with the percentage of individual FEV~1~ performances (performed % of the predicted value from age, sex and BMI based population studies) by means of polynomial regression (SigmaPlot; version 13).
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![Relative changes in normalized alveolar concentrations of 18 selected compounds and respiratory parameters from 50 healthy volunteers.\
A schematic spirogram profile of exhaled breaths is presented on the top of the figure. Protonated compounds were tentatively identified based on their m/z ratio. VOC concentrations and respiratory parameters were normalized onto values in the third exhalation ('N'). The beginning and the end of the second minute is represented by two vertical black lines. FEV manoeuvre was performed at the beginning of 2^nd^ minute. During the manoeuvre the maximum exhalation point is marked as 'M' and the forced expiration point is marked as 'F'. VTex = expiratory tidal volume, pET-CO~2~ = end-tidal partial pressure of carbon dioxide, VE = minute ventilation and FIO~2~ = fraction of inspiratory oxygen.](srep28029-f1){#f1}

![Time profiles of normalized exhaled alveolar substance concentrations, respiratory and hemodynamic parameters from 50 healthy volunteers.\
Diagram (**A**) represents the changes for hemodynamic \[Cardiac Output, Stroke Volume and Pulse Rate\] parameters (on top), VOC \[Isoprene, Furan and C~2~H~6~S\] concentrations (in middle) and respiratory \[VTex and VE\] parameters (at bottom). Diagram (**B**) shows changes for VE in primary Y axis and that of Cardiac Output in secondary Y axis (on top), VOC \[Acetonitrile and C~4~H~8~S\] concentrations (middle) and pET-CO~2~ and Acetone (bottom). The vertical black lines at 60^th^ and 120^th^ second represent the beginning and end of the second minute. The data points for normalization are indicated as 'N'. "M" and "F" represent the end of Max~out~ and Forced~out~, respectively. Coloured error bars represent standard deviations. A schematic spirogram profile of exhaled breaths is presented on the top of each diagram.](srep28029-f2){#f2}

![Polynomial regression models for percentages of decrease in alveolar isoprene concentration and percentages of FEV~1~ performance.\
The percentages of performed FEV~1~ are plotted in X-axis, Y-axis represents relative decrease in isoprene concentration. Two orders of regression equations along with the respective R2 values are presented. Isoprene decreased as the function of FEV~1~ performance, which is illustrated with a negative slope. Red lines are regressions lines of 1^st^ and 2^nd^ order.](srep28029-f3){#f3}

![Experimental setup \[**A**\] and the measurement protocol \[**B**\] of the study. \[**A**\] Parallel monitoring of breath VOCs by PTR-TOF-MS (**1**), lung function parameters and pET-CO~2~ by means of spirometry and capnometry (**2**) and hemodynamic parameters such as SV = stroke volume, CO = cardiac output, PR = pulse rate and MAP = mean arterial pressure (**3**). **\[B\]** Schematic spirogram of the whole experiment during tidal breathing and FEV manoeuvre. Spirogram of FEV manoeuver: VC = vital capacity, VT = tidal volume, ERV = expiratory reserve volume, IRV = inspiratory reserve volume, IC = inspiratory capacity, RV = residual volume and TLC = total lung capacity.](srep28029-f4){#f4}

###### Changes in normalized concentrations of six different VOCs and changes (A,B) in normalized values of respiratory (A) and hemodynamic parameters (B).

  **A**                                                                                                                                                                                                                      
  ------------------------------------- -------- -------- -------------------------------------- ------------------------------- ------------------------------- -------- ------------ ------------------------------------- -----------------------------
  Comparison point                       1^st^    4^th^                     0                                  N/A                      Comparison point          1^st^      4^th^                       0                                N/A
  (Isoprene)H^+^69.06989                 1^st^    8^th^                    6.08                              \<0.001              Expiratory tidal volume \[L\]   1^st^      8^th^                     −8.57                             0.070
  1^st^                                  12^th^   11.12                   0.001                               1^st^                          12^th^               −8.03      0.175                                           
  2^nd^                                   Max     21.18                  \<0.001                              2^nd^                            Max                106.28    \<0.001                                          
  2^nd^                                  Forced   −18.41                 \<0.001                              2^nd^                          Forced               291.66    \<0.001                                          
  2^nd^                                  4^th^    −37.26                 \<0.001                              2^nd^                           4^th^               164.99    \<0.001                                          
  2^nd^                                  8^th^    21.16                  \<0.001                              2^nd^                           8^th^                7.30     \<0.001                                          
  3^rd^                                  1^st^    12.33                  \<0.001                              3^rd^                           1^st^               −0.11      0.020                                           
  3^rd^                                  5^th^     1.62                   0.668                               3^rd^                           5^th^               −4.67      0.063                                           
  3^rd^                                  9^th^    −5.03                  \<0.001                              3^rd^                           9^th^               −7.57      0.004                                           
  Comparison point                       1^st^    4^th^                     0                                  N/A                      Comparison point          1^st^      4^th^                       0                                N/A
  (C~2~H~6~S)H^+^ 63.0263                1^st^    8^th^                    1.31                               0.914               Minute ventilation \[L/min\]    1^st^      8^th^                     −5.74                             0.020
  1^st^                                  12^th^    1.68                   0.668                               1^st^                          12^th^               −6.91      0.282                                           
  2^nd^                                   Max      6.99                  \<0.001                              2^nd^                            Max                41.36     \<0.001                                          
  2^nd^                                  Forced   −5.79                  \<0.001                              2^nd^                          Forced               171.40    \<0.001                                          
  2^nd^                                  4^th^    −12.75                 \<0.001                              2^nd^                           4^th^               145.77    \<0.001                                          
  2^nd^                                  8^th^     4.96                  \<0.001                              2^nd^                           8^th^               11.16     \<0.001                                          
  3^rd^                                  1^st^     3.90                  \<0.001                              3^rd^                           1^st^               −0.19      0.154                                           
  3^rd^                                  5^th^    −1.50                  \<0.001                              3^rd^                           5^th^               −3.57      0.336                                           
  3^rd^                                  9^th^    −2.33                  \<0.001                              3^rd^                           9^th^               −7.10      0.008                                           
  Comparison point                       1^st^    4^th^                     0                                  N/A                      Comparison point          1^st^      4^th^                       0                                N/A
  (Acetone)H^+^ 59.04914                 1^st^    8^th^                   −0.27                              \<0.001                   pET− CO~2~ \[kPa\]         1^st^      8^th^                     −0.73                             0.203
  1^st^                                  12^th^    0.25                   0.086                               1^st^                          12^th^               −2.41     \<0.001                                          
  2^nd^                                   Max      0.02                   0.238                               2^nd^                            Max                 6.08     \<0.001                                          
  2^nd^                                  Forced    4.45                  \<0.001                              2^nd^                          Forced               −18.28    \<0.001                                          
  2^nd^                                  4^th^     1.41                  \<0.001                              2^nd^                           4^th^               −24.80    \<0.001                                          
  2^nd^                                  8^th^     1.32                   0.001                               2^nd^                           8^th^               −7.91     \<0.001                                          
  3^rd^                                  1^st^     1.11                   0.009                               3^rd^                           1^st^               −9.20     \<0.001                                          
  3^rd^                                  5^th^     0.54                   0.053                               3^rd^                           5^th^               −10.82    \<0.001                                          
  3^rd^                                  9^th^     0.76                   0.418                               3^rd^                           9^th^               −11.53    \<0.001                                          
  B                                                                                                                                                                                                                          
  Protonated VOCs Mass \[gm mol^−1^\]    Minute   Breath   (%) Change of normalized mean values   Significance/Breath (P-value)      Hemodynamic parameters       Minute   Time \[s\]   (%)Change of normalized mean values   Significance/Time (P-value)
  Comparison point                       1^st^    4^th^                     0                                  N/A                      Comparison point          1^st^     40^th^ s                     0                                N/A
  (Acetonitrile)H^+^42.03382             1^st^    8^th^                   −3.34                               0.125                 Stroke volume \[ml/beat\]                                                                               
  1^st^                                  12^th^   −2.16                   0.001                               1^st^                            60s                −0.27      0.819                                           
  2^nd^                                   Max      1.71                  \<0.001                              2^nd^                            20s                −14.17    \<0.001                                          
  2^nd^                                  Forced   −0.26                   0.001                               2^nd^                            40s                 3.74     \<0.001                                          
  2^nd^                                  4^th^    −4.73                   0.257                               2^nd^                            60s                 2.12     \<0.001                                          
  2^nd^                                  8^th^    −2.46                   0.048                               3^rd^                            20s                −1.04      0.014                                           
  3^rd^                                  1^st^    −2.94                   0.005                               3^rd^                            40s                −1.43      0.003                                           
  3^rd^                                  5^th^    −4.94                   0.008                               3^rd^                            60s                −2.39     \<0.001                                          
                                         3^rd^    9^th^                   −5.64                               0.007                                                                                                                         
  Comparison point                       1^st^    4^th^                     0                                  N/A                      Comparison point          1^st^     40^th^ s                     0                                N/A
  (Furan)H^+^ 69.03349                   1^st^    8^th^                    7.11                              \<0.001                Cardiac output \[L/min\]                                                                                
  1^st^                                  12^th^    3.43                   0.001                               1^st^                            60s                 0.14     \<0.001                                          
  2^nd^                                   Max     11.83                  \<0.001                              2^nd^                            20s                −6.45     \<0.001                                          
  2^nd^                                  Forced   −16.27                 \<0.001                              2^nd^                            40s                14.49     \<0.001                                          
  2^nd^                                  4^th^    −32.20                 \<0.001                              2^nd^                            60s                 1.80      0.001                                           
  2^nd^                                  8^th^    13.43                  \<0.001                              3^rd^                            20s                −1.22      0.120                                           
  3^rd^                                  1^st^     4.68                  \<0.001                              3^rd^                            40s                −0.99      0.040                                           
  3^rd^                                  5^th^    −3.25                  \<0.001                              3^rd^                            60s                −1.58      0.127                                           
                                         3^rd^    9^th^                   −5.43                              \<0.001                                                                                                                        
  Comparison point                       1^st^    4^th^                     0                                  N/A                      Comparison point          1^st^     40^th^ s                     0                                N/A
  (C~4~H~8~S)H^+^ 89.04195               1^st^    8^th^                   −1.38                               1.000                 Pulse rate \[beats/min\]                                                                                
  1^st^                                  12^th^   −1.59                   0.253                               1^st^                            60s                 0.21      0.794                                           
  2^nd^                                   Max      0.09                   0.002                               2^nd^                            20s                12.04     \<0.001                                          
  2^nd^                                  Forced   −11.61                 \<0.001                              2^nd^                            40s                10.70     \<0.001                                          
  2^nd^                                  4^th^    −10.40                 \<0.001                              2^nd^                            60s                −0.74      0.018                                           
  2^nd^                                  8^th^    −2.92                   0.005                               3^rd^                            20s                −0.40      0.819                                           
  3^rd^                                  1^st^    −3.64                   0.039                               3^rd^                            40s                 0.40      0.038                                           
  3^rd^                                  5^th^    −8.14                  \<0.001                              3^rd^                            60s                 0.88      0.006                                           
                                         3^rd^    9^th^                   −8.12                              \<0.001                                                                                                                        

VOC concentrations from every forth exhalation as well as from the maximum and forced expiration of the second minute were compared to the 4^th^ breath of the first minute. Respiratory parameters were compared in the same way. (%) *Change of normalized mean values*: Positive values represent an increase and negative values represent a decrease. *Significance/Breath*: differences between the reference value and actual values were assessed by means of repeated measurement-ANOVA on ranks. Hemodynamic parameters were compared with the 40^th^ s of the first minute. *Significance/Time*: differences between the reference value and actual values were assessed by means of repeated measurement-ANOVA on ranks.

###### Overall results of polynomial regressions.

  **Order**    **R**^**2**^   **F-test**   **P-value**
  ----------- -------------- ------------ -------------
  1^st^           0.797         86.477       \<0.001
  2^nd^           0.855         62.032       \<0.001
  3^rd^           0.856         39.504       \<0.001

The strengths of correlations between models and response variables are represented as R^2^ values. F-test simultaneously accesses multiple coefficients of regression and compares the fits of different linear models. The P-values stand for the statistical significance of corresponding F-test.

###### Demographic data of healthy volunteers.

  **ID**    **Age (years)**   **Sex**   **Height \[cm\]**   **Weight \[kg\]**   **Smoker**   **BMI**   **ID**   **Age (years)**   **Sex**   **Height \[cm\]**   **Weight \[kg\]**   **Smoker**   **BMI**
  -------- ----------------- --------- ------------------- ------------------- ------------ --------- -------- ----------------- --------- ------------------- ------------------- ------------ ---------
  1               30             M             168                 64               No         23        26           32             M             172                 69               No         23
  2               32             M             184                 72               No         21        27           29             F             169                 78              Yes         27
  3               29             M             186                 80               No         23        28           32             M             166                 65               No         24
  4               26             M             183                 72               No         22        29           29             M             166                 62               No         22
  5               28             M             168                 72               No         26        30           28             F             173                 68               No         23
  6               26             F             165                 72               No         26        31           33             F             170                 68               No         24
  7               29             M             177                 70              Yes         22        32           28             F             170                 66               No         23
  8               28             M             193                 85               No         23        33           25             M             167                 65               No         23
  9               26             F             170                 63               No         22        34           31             M             171                 68               No         23
  10              25             F             162                 50               No         19        35           28             F             167                 62               No         22
  11              28             F             171                 90               No         30        36           27             M             162                 79               No         30
  12              46             M             186                 75               No         22        37           25             F             158                 49               No         20
  13              47             M             195                 103              No         27        38           23             M             185                 65               No         19
  14              22             F             170                 66               No         23        39           34             M             180                 90               No         28
  15              31             M             162                 63               No         24        40           24             F             172                 65               No         22
  16              31             M             169                 70               No         24        41           29             M             164                 67               No         25
  17              26             F             181                 68               No         21        42           24             M             163                 62               No         23
  18              43             F             168                 60              Yes         21        43           30             M             190                 91              Yes         25
  19              54             M             189                 106              No         30        44           29             F             169                 65               No         23
  20              34             M             172                 75               No         25        45           31             F             172                 71               No         24
  21              20             M             188                 83               No         24        46           22             F             178                 70               No         22
  22              26             M             169                 68               No         24        47           27             F             170                 68              Yes         24
  23              31             F             172                 68               No         23        48           46             F             165                 62               No         23
  24              23             F             168                 68               No         24        49           27             F             168                 70              Yes         25
  25              21             F             180                 68               No         21        50           32             M             170                 67               No         23

Data regarding participants' age, sex, height, body weight, smoking habit and body mass index (BMI) are presented.

###### PTR-ToF-MS-8000 measurement parameters for our study.

  **Transfer line**    **Ion source**   **PTR drift tube**   **ToF-MS**                                                   
  ------------------- ---------------- -------------------- ------------ ------------- --------- ------------ ----------- -------------------
  *Inlet Flow*            *Temp.*          *Inlet Flow*      *Current*    *E/N Ratio*   *Temp.*   *Pressure*   *Voltage*   *Mass resolution*
  20 sccm                  75 °C            6--7 sccm         4--5 mA     137--139 Td    75 °C     2.3 mbar      610 V      4000--5000 FWHM

Optimised operating values for transfer line, ion source, PTR drift tube and time of flight-mass spectrometry (ToF-MS) are presented.
